Search

Valerie Rodriguez-garcia

Examiner (ID: 13670, Phone: (571)270-5865 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1622, 1621, 1759, 1626
Total Applications
1146
Issued Applications
752
Pending Applications
83
Abandoned Applications
331

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4803609 [patent_doc_number] => 20080015198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Substituted pyrazoline compounds, their preparation and use as medicaments' [patent_app_type] => utility [patent_app_number] => 10/589744 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17153 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015198.pdf [firstpage_image] =>[orig_patent_app_number] => 10589744 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/589744
Substituted pyrazoline compounds, their preparation and use as medicaments Feb 15, 2005 Abandoned
Array ( [id] => 5297118 [patent_doc_number] => 20090012044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Novel Hiv Protease Inhibitors' [patent_app_type] => utility [patent_app_number] => 10/597408 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15221 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012044.pdf [firstpage_image] =>[orig_patent_app_number] => 10597408 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/597408
Chemical composition with borane clusters for use as an HIV protease inhibitor Jan 26, 2005 Issued
Array ( [id] => 4720120 [patent_doc_number] => 20080242643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclooxygenase-2 Inhibitors' [patent_app_type] => utility [patent_app_number] => 10/586381 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9785 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242643.pdf [firstpage_image] =>[orig_patent_app_number] => 10586381 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586381
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors Jan 24, 2005 Issued
Array ( [id] => 4823180 [patent_doc_number] => 20080227758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Nitric Oxide Releasing Prodrugs of Diaryl-2-(5h)-Furanones as Cyclooxygenase-2 Inhibitors' [patent_app_type] => utility [patent_app_number] => 10/586573 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10841 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227758.pdf [firstpage_image] =>[orig_patent_app_number] => 10586573 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586573
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors Jan 24, 2005 Issued
Array ( [id] => 4705350 [patent_doc_number] => 20080064874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => '2-Halofuryl/Thienyl-3-Carboxamides' [patent_app_type] => utility [patent_app_number] => 10/588293 [patent_app_country] => US [patent_app_date] => 2005-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27109 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064874.pdf [firstpage_image] =>[orig_patent_app_number] => 10588293 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/588293
2-Halofuryl-thienyl-3-carboxamides Jan 21, 2005 Issued
Array ( [id] => 7250666 [patent_doc_number] => 20050272741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Novel methods of treatment for Fontan patients with protein losing enteropathy' [patent_app_type] => utility [patent_app_number] => 11/037966 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2432 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272741.pdf [firstpage_image] =>[orig_patent_app_number] => 11037966 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/037966
Novel methods of treatment for Fontan patients with protein losing enteropathy Jan 17, 2005 Abandoned
Array ( [id] => 4922612 [patent_doc_number] => 20080070928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Novel 2-Heteroaryl-Substituted Benzimidazole Derivative' [patent_app_type] => utility [patent_app_number] => 10/582564 [patent_app_country] => US [patent_app_date] => 2004-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 148628 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070928.pdf [firstpage_image] =>[orig_patent_app_number] => 10582564 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582564
2-heteroaryl-substituted benzimidazole derivative Dec 27, 2004 Issued
Array ( [id] => 4682928 [patent_doc_number] => 20080249154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates' [patent_app_type] => utility [patent_app_number] => 10/584280 [patent_app_country] => US [patent_app_date] => 2004-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24945 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249154.pdf [firstpage_image] =>[orig_patent_app_number] => 10584280 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584280
Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates Dec 23, 2004 Abandoned
Array ( [id] => 5063527 [patent_doc_number] => 20070225167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => '2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Tetramic Acid Derivatives as Pest Control Agents and/or Herbicides' [patent_app_type] => utility [patent_app_number] => 10/579099 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27344 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225167.pdf [firstpage_image] =>[orig_patent_app_number] => 10579099 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/579099
2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Tetramic Acid Derivatives as Pest Control Agents and/or Herbicides Nov 8, 2004 Abandoned
Array ( [id] => 5199651 [patent_doc_number] => 20070298969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => '2-Ethyl-4,6-Dimethyl-Phenyl-Substituted Spirocyclic Tetramic Acid Derivatives' [patent_app_type] => utility [patent_app_number] => 10/578900 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23251 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298969.pdf [firstpage_image] =>[orig_patent_app_number] => 10578900 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/578900
2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives Nov 8, 2004 Issued
Array ( [id] => 4652379 [patent_doc_number] => 20080039635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Method for the Production of a Compound, Comprising a Free Hydroxyl Group and a Hydroxyl Group Which is Protected by an Ester Function by Enzymatic Reaction' [patent_app_type] => utility [patent_app_number] => 10/576773 [patent_app_country] => US [patent_app_date] => 2004-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4517 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039635.pdf [firstpage_image] =>[orig_patent_app_number] => 10576773 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/576773
Method for the Production of a Compound, Comprising a Free Hydroxyl Group and a Hydroxyl Group Which is Protected by an Ester Function by Enzymatic Reaction Oct 18, 2004 Abandoned
Array ( [id] => 4887913 [patent_doc_number] => 20080262245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Process for the Preparation of Amorphous Fluvastatin Sodium' [patent_app_type] => utility [patent_app_number] => 11/576714 [patent_app_country] => US [patent_app_date] => 2004-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 824 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262245.pdf [firstpage_image] =>[orig_patent_app_number] => 11576714 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576714
Process for the preparation of amorphous fluvastatin sodium Oct 4, 2004 Issued
Array ( [id] => 5068917 [patent_doc_number] => 20070190018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Dual phase drug release system' [patent_app_type] => utility [patent_app_number] => 10/570466 [patent_app_country] => US [patent_app_date] => 2004-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29024 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190018.pdf [firstpage_image] =>[orig_patent_app_number] => 10570466 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/570466
Dual phase drug release system Sep 3, 2004 Issued
Array ( [id] => 185181 [patent_doc_number] => 07648997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-19 [patent_title] => 'Hydroxylamine substituted imidazoquinolines' [patent_app_type] => utility [patent_app_number] => 10/595058 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39378 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/648/07648997.pdf [firstpage_image] =>[orig_patent_app_number] => 10595058 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/595058
Hydroxylamine substituted imidazoquinolines Aug 11, 2004 Issued
Array ( [id] => 4705167 [patent_doc_number] => 20080064691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory Activity' [patent_app_type] => utility [patent_app_number] => 10/566063 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39219 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064691.pdf [firstpage_image] =>[orig_patent_app_number] => 10566063 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/566063
Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory Activity Aug 3, 2004 Abandoned
Array ( [id] => 131919 [patent_doc_number] => 07700619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => '2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts' [patent_app_type] => utility [patent_app_number] => 10/566384 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4798 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700619.pdf [firstpage_image] =>[orig_patent_app_number] => 10566384 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/566384
2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts Jul 28, 2004 Issued
Array ( [id] => 7075253 [patent_doc_number] => 20050148521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Anti-cancer combination and use thereof' [patent_app_type] => utility [patent_app_number] => 10/898721 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8375 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148521.pdf [firstpage_image] =>[orig_patent_app_number] => 10898721 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/898721
Anti-cancer combination and use thereof Jul 22, 2004 Abandoned
Array ( [id] => 5000386 [patent_doc_number] => 20070043020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds' [patent_app_type] => utility [patent_app_number] => 10/563708 [patent_app_country] => US [patent_app_date] => 2004-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11999 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043020.pdf [firstpage_image] =>[orig_patent_app_number] => 10563708 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/563708
Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds Jul 6, 2004 Issued
Array ( [id] => 5101870 [patent_doc_number] => 20070185132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo' [patent_app_type] => utility [patent_app_number] => 10/559869 [patent_app_country] => US [patent_app_date] => 2004-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19630 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185132.pdf [firstpage_image] =>[orig_patent_app_number] => 10559869 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559869
Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo Jun 28, 2004 Abandoned
Array ( [id] => 7060535 [patent_doc_number] => 20050002895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Methods and compositions for controlled release of drugs' [patent_app_type] => utility [patent_app_number] => 10/859472 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21813 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002895.pdf [firstpage_image] =>[orig_patent_app_number] => 10859472 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/859472
Methods and compositions for controlled release of drugs May 31, 2004 Issued
Menu